H
H. Bob Smouse
Researcher at St. Francis Medical Center
Publications - 9
Citations - 1320
H. Bob Smouse is an academic researcher from St. Francis Medical Center. The author has contributed to research in topics: Inferior vena cava & Stent. The author has an hindex of 7, co-authored 9 publications receiving 1152 citations. Previous affiliations of H. Bob Smouse include OSF Saint Francis Medical Center.
Papers
More filters
Journal ArticleDOI
Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease Twelve-Month Zilver PTX Randomized Study Results
Michael D. Dake,Gary M. Ansel,Michael R. Jaff,Takao Ohki,Richard R. Saxon,H. Bob Smouse,Thomas Zeller,Gary S. Roubin,Mark W. Burket,Yazan Khatib,Scott A. Snyder,Anthony Ragheb,J. King White,Lindsay S. Machan +13 more
TL;DR: Femoropopliteal peripheral artery disease treatment with the paclitaxel-eluting stent was associated with superior 12-month outcomes compared with PTA and provisional bare metal stent placement.
Journal ArticleDOI
Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial
Michael D. Dake,Gary M. Ansel,Michael R. Jaff,Takao Ohki,Richard R. Saxon,H. Bob Smouse,Lindsay S. Machan,Scott A. Snyder,Erin E. O’Leary,Anthony Ragheb,Thomas Zeller +10 more
TL;DR: In this paper, a randomized controlled trial evaluated clinical durability of Zilver PTX, a paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions.
Journal ArticleDOI
Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies.
Michael D. Dake,Gary M. Ansel,Michael R. Jaff,Takao Ohki,Richard R. Saxon,H. Bob Smouse,Scott A. Snyder,Erin E. O’Leary,Gunnar Tepe,Dierk Scheinert,Thomas Zeller,Zilver Ptx Investigators +11 more
TL;DR: Two-year outcomes with the paclitaxel-eluting stent support its sustained safety and effectiveness in patients with femoropopliteal artery disease, including the long-term superiority of the DES to PTA and to provisional bare-metal stent placement.
Journal ArticleDOI
Long-term Retrieval Success Rate Profile for the Günther Tulip Vena Cava Filter
H. Bob Smouse,David Rosenthal,Thuong G. Van Ha,Michael F. Knox,Robert G. Dixon,William D. Voorhees,Jennifer A. McCann-Brown +6 more
TL;DR: This study contributes to the body of clinical data related to retrievable filters, demonstrating reliable retrieval rates at 12 weeks, with successful retrievals up to 17 months after implantation.
Journal ArticleDOI
Nine-month results of the REFORM study: a prospective, single-arm, multicenter clinical study of the safety and effectiveness of the Formula™ balloon-expandable stent for treatment of renal artery stenosis.
Robert M. Bersin,Gary M. Ansel,Anthony Rizzo,H. Bob Smouse,Shantanu Sinha,Ravish Sachar,Rajesh Dave,Barry S. Weinstock,Robert L. Feldman,Gary S. Roubin +9 more
TL;DR: The 9‐month safety and effectiveness outcomes of the Formula™ balloon‐expandable renal stent for the treatment of atherosclerotic renal artery stenosis (RAS) following suboptimal angioplasty are evaluated.